Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717586 · ClinicalTrials.gov registry record · Phase 1
Pravastatin for Prevention of Preeclampsia
A Phase 1 study of Preeclampsia, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 3
- Study locations
NCT01717586 is a Phase 1 study of Preeclampsia that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 48 participants, below the 1,281-participant average among 39 other Preeclampsia trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT01717586, a Phase 1 study of Preeclampsia, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary purpose of this pilot study is to determine the pharmacokinetic (PK) parameters and collect preliminary safety data for pravastatin when used as a prophylactic daily treatment in pregnant women at high risk of preeclampsia.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pravastatin
Study Locations (3)
Illinois
- Northwestern University - Chicago
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2012-08 |
| Est. Completion | 2024-02-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01717586
The ClinicalTrials.gov registry entry for NCT01717586 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,281-participant average among 39 other Preeclampsia trials with a reported enrollment target (96% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preeclampsia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01717586 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Pennsylvania, Texas.
Frequently Asked Questions
What is clinical trial NCT01717586 about?
NCT01717586 is a clinical study titled "Pravastatin for Prevention of Preeclampsia". The primary purpose of this pilot study is to determine the pharmacokinetic (PK) parameters and collect preliminary safety data for pravastatin when used as a prophylactic daily treatment in pregnant women at high risk of preeclampsia.
What is the current status of trial NCT01717586?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2012-08. Estimated completion is 2024-02-12.
What conditions does trial NCT01717586 study?
This clinical trial studies the following conditions: Preeclampsia.
What interventions are being tested in trial NCT01717586?
The interventions under investigation include: Placebo (DRUG), Pravastatin (DRUG).
Who is sponsoring clinical trial NCT01717586?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01717586 being conducted?
This trial has 3 study locations across Illinois, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.